A Cambridge, MA company "Moderna" has released the results of
their Phase 1 tests of a covid-19 vaccine and has been given
the go-ahead to proceed to phase II testing.

If the results of Phase II are successful, an emergency
go-ahead to start full scale immunizations may be
forthcoming as early as this fall.

The vaccine was tested in three dosages. Even the lowest
dosage resulted in antibodies to fight the virus at a
level similar to those people who contacted covid-19 and
survived.

Details he

https://www.statnews.com/2020/05/18/early-data-show-moderna-covid-19-vaccine-generates-immune-response/

--
This email has been checked for viruses by AVG.
https://www.avg.com